3 suspended. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Suspended 3 |
| Phase 2 | 1 | Suspended 1 |
Follow Covid19: new trials by email Literature Review of Covid19 trials Research Report on Covid19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Measles Vaccine in HCW Measles-Mumps-Rubella Vaccine, Placebos - Covid19 | Phase 3 | Suspended | Kasr El Aini Hospital | 200 | 2020-07-13 | 2020-12-22 |
| Proactive Care of Ambulatory COVID19 Patients consultation, Azithromycin - Covid19, Azithromycin | Phase 3 | Suspended | Centre Hospitalier Universitaire, Amiens | 11 | 2020-04-29 | 2023-03-21 |
| Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO Sarilumab, Azithromycin, Hydroxychloroquine - COVID19, SARS-CoV-2 Infection | Phase 2 / Phase 3 | Suspended | Assistance Publique - Hôpitaux de Paris | 27 | 2020-04-11 | 2020-05-06 |
COVID-19 (3) · Respiratory Insufficiency (1)
Coronaviridae Infections (3) · Coronavirus Infections (3) · Infections (3) · Lung Diseases (3) · Nidovirales Infections (3) · Pneumonia (3) · Pneumonia, Viral (3) · RNA Virus Infections (3) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Virus Diseases (3) · Respiration Disorders (1)
Azithromycin (2) · Hydroxychloroquine (1) · Measles-Mumps-Rubella Vaccine (1) · Referral and Consultation (1) · sarilumab (1)
Assistance Publique - Hôpitaux de Paris (1) · Centre Hospitalier Universitaire, Amiens (1) · Kasr El Aini Hospital (1)
France (2) · Egypt (1)